**Abstract**

**Specific Objective:** *SLC1A2* encoding excitatory amino acid transporter 2 (EAAT2), the principal transporter clearing synaptic glutamate, is a candidate gene for bipolar disorder (BD). The aim of this study was to examine the differences in methylation of the *SLC1A2* promoter between BD and non-psychiatric subjects (NPS).

**Methods:** 150 BD subjects from the Mayo Clinic Bipolar Biobank were equally divided into five groups: (1) BD without comorbid alcohol use disorder (AD), nicotine use disorder (ND), or binge eating disorder (BE); (2) BD+AD; (3) BD+ND; (4) BD+ND+AD; and (5) BD+BE. Mayo Clinic Community Biobank provided NPS samples (n=32). First, we performed bisulfite conversion and methylation-sensitive high-resolution melt (HRM) PCR to examine methylation status of the two *SLC1A2* promoter regions. To validate our findings, we employed TA cloning and DNA sequencing to map the whole 156 CpG sites in the approximately 2kb promoter region of the *SLC1A2*. One-way analysis of variance (ANOVA) and general linear regression model were used for the statistical analysis.

**Summary of Results:** HRM analysis in the CpG island between -1759 and -1468 revealed difference between the groups (p=0.0003). BD with comorbidities were hypomethylated compared to BD, while females showed hypermethylation (p=0.036). HRM PCR in CpG island between -785 and -654 revealed hypomethylation in BD with comorbidities in comparison to BD (p\<0.0001). BD was a predictor of hypermethylation (p=0.035). In our complete sequencing study, we identified that CpG site \#6 was hypermethylated in BD compared to NPS (p=0.05). CpG sites \#3 (p=0.05) and \#156 (p=0.04) were hypomethylated in BD+AD+ND compared to NPS. CpG sites \#6 (p=0.01) and \#48 (p=0.03) were hypomethylated in BD+AD+ND compared to BD.

**Conclusions:** DNA methylation is altered in two distinct regions of *SLC1A2* promoter of BD patients. Addiction comorbidities have a significant impact on the level of promoter hypomethylation. HRM analysis was validated through bisulfite sequencing.
